Treatment of non-small cell lung cancer (NSCLC)

Radical surgery is the standard of care for fit stage I non-small cell lung cancer (NSCLC) patients. Adjuvant treatment should be offered only as part of an investigation trial. Stage II and IIIA adjuvant cisplatin-based chemotherapy remains the gold standard for completely resected NSCLC tumors. Ad...

詳細記述

保存先:
書誌詳細
主要な著者: Zarogoulidis, Konstantinos, Zarogoulidis, Paul, Darwiche, Kaid, Boutsikou, Efimia, Machairiotis, Nikolaos, Tsakiridis, Kosmas, Katsikogiannis, Nikolaos, Kougioumtzi, Ioanna, Karapantzos, Ilias, Huang, Haidong, Spyratos, Dionysios
フォーマット: Artigo
言語:Inglês
出版事項: Pioneer Bioscience Publishing Company 2013
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3791496/
https://ncbi.nlm.nih.gov/pubmed/24102012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.07.10
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料